NCT06296927

Brief Summary

This study was planned to determine the effect of Emotional Freedom Technique on perceived pain level, situational anxietyl and satisfaction level during mammography screening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

November 7, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

February 27, 2024

Last Update Submit

May 12, 2025

Conditions

Keywords

mammographypainEmotional Freedom Technique

Outcome Measures

Primary Outcomes (2)

  • Anxiety

    Data will be collected using the State Anxiety Inventory. The answer options collected in four classes on the State Anxiety Inventory scale are: (1) Not at all, (2) A little, (3) A lot and (4) Completely; The options on the trait anxiety scale are (1) Rarel, (2) Sometimes, (3) A lot of the time, and (4) Almost always. The higher the score obtained from the scales, the higher the person's anxiety is. The total score obtained from the scale varies between 20-80, and 20-39 indicates a mild anxiety level, 40-59 indicates a medium anxiety level, 60-79 indicates a high anxiety level, and 80 points indicates a panic anxiety level.

    20 minute

  • Pain Level

    Data will be collected using the Visual Analogue Scale. Pain can be given a score between 0 and 10 on the scale.The higher the scale score, the greater the pain.

    10 minute

Secondary Outcomes (4)

  • Satisfaction Level

    10 minutes

  • Blood Pressure

    5 minutes

  • Thermometer

    5 minutes

  • Saturation

    5 minutes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Emotional Freedom Technique will be applied to women in the intervention group applying for mammography screening 30-40 minutes before the procedure.

Other: Emotional Freedom Technique

Control Group

NO INTERVENTION

Women in the control group applying for mammography screening will not receive any intervention other than routine mammography screening.

Interventions

The researcher will apply the Emotional Freedom Technique to women in the intervention group who apply for mammography screening for 30-40 minutes before the screening.

Intervention Group

Eligibility Criteria

Age40 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Having a first mammography screening
  • Knowing how to read and write,
  • Having entered menopause (at least 1 year has passed since the last menstruation)

You may not qualify if:

  • Having any cognitive or hearing problems,
  • Having used painkillers before the procedure,
  • Having no chronic diseases (cardiovascular, respiratory tract),
  • Having a diagnosed mental illness (schizophrenia, bipolar disorder),
  • Having epilepsy (as it is a contraindication for EFT applications),

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pendik District Health Directorate Maternal Child Health and Family Planning Center

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study is a randomized controlled two-group study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator Midwife

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 6, 2024

Study Start

November 7, 2024

Primary Completion

February 28, 2025

Study Completion

March 30, 2025

Last Updated

May 13, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations